EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Blood Neoplasia

ISSN 2950-3280 · Elsevier BV

Neueste Artikel

  1. Increased severe neurotoxicity and hospital stay in octogenarians receiving CAR T-cell therapy for large B-cell lymphoma

    Dasom Lee, Masooma S. Rana, Alexandria Jensen, Edna Cheung, Nima Ghalehsari, William Wang, Eric Heng, Humza Khan, Bita Sahaf, Jayasindhu Mallampet, Sheila Lahijani, Faisal Cheema, Lauren S. Maeda, Connie Chen, Lekha Mikkilineni, Surbhi Sidana, Melody Smith, Wen-Kai Weng, Sushma Bharadwaj, Matthew J. Frank, David B. Miklos, Saurabh Dahiya

    Erschienen: 2026-11DOI: 10.1016/j.bneo.2026.100297

  2. Circulating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies

    Binod Dhakal, Michael Slade, Alberto Ferrarini, Paola Tononi, Marla Ruzicka, Aniko Szabo, Othman Akhtar, Jasper Olsem, Ravi Narra, Mark Schroeder, Hima Bansal, Maria Jose Acevedo-Calado, Oren Pasvolsky, Mahmoud R. Gaballa, Khanmi Kasomva, Melody R. Becnel, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, J Christine Ye, Meera Mohan, Fumou Sun, Zoltan Simandi, Sabari Radhakrishnan, Keith Stockert-Goldtsein, Wojciech Swat, Frank Kuhr, Ravi Vij, Federica Sola, Giuseppe Giacomo Montefrancesco, Marianna Garonzi, Nicolò Manaresi, Anita D’Souza, Robert Z Orlowski, Hans C. Lee

    Erschienen: 2026-11DOI: 10.1016/j.bneo.2026.100332

  3. Prospective Analyses of the Utility of Liquid Biopsy in Patients with Fever of Unknown Origin Suspected of Lymphoma

    Akinao Okamoto, Masashi Sanada, Takahiko Yasuda, Seiichi Kato, Akira Satou, Takuma Ishihara, Kosei Matsue, Hiroki Hosoi, Masahiro Yoshida, Satsuki Murakami, Eisei Kondo, Yasufumi Masaki, Yasuhiro Suzuki, Kana Miyazaki, Tomohiro Kajiguchi, Junji Hiraga, Shingo Kurahashi, Yuichiro Inagaki, Kazutaka Ozeki, Shigeki Saito, Toshiki Terao, Sachiko Iba, Keiko Hattori, Hideyuki Yamamoto, Naoe Goto, Chisako Iriyama, Masataka Okamoto, Akihiro Tomita

    Erschienen: 2026-10DOI: 10.1016/j.bneo.2026.100321

  4. Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma

    Alexander D. Sanjurjo, David DeStephano, Justine Kahn, Melissa Beauchemin, Caitlin Gribbin, Rajbir Toor, Jia Ruan, Kelly Meza, Eduardo Edelman Saul, Bryan Valcarcel, Luis Malpica, Kimberly Seymour, Nicholas Li, R. Alejandro Sica, Rahul Nayak, Pamela Allen, Meghana Subramanian, Yun Kyoung Tiger, Alexandra Lyubimova, Leily Santos-Carrion, Carla Romagnoli, Jacqueline Barrientos, Miguel Ruiz, Jonathan Brammer, Haris Qureshi, Francine Foss, Tarsheen Sethi, Omar Elghawy, Stefan Barta, Can Jones, Jose Sandoval-Sus, Hua-Jay J. Cherng, Barbara Pro, Jennifer E. Amengual, Seda S. Tolu

    Erschienen: 2026-10DOI: 10.1016/j.bneo.2026.100328

  5. Ten-day decitabine vs “3+7” in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21

    Michael Lübbert, Pierre W. Wijermans, Michal Kicinski, Sylvain Chantepie, Walter J. F. M. Van der Velden, Richard Noppeney, Laimonas Griškevičius, Andreas Neubauer, Martina Crysandt, Radovan Vrhovac, Mario Luppi, Stephan Fuhrmann, Ernesta Audisio, Anna Candoni, Olivier Legrand, Robin Foà, Gianluca Gaidano, Danielle van Lammeren-Venema, Eduardus F. M. Posthuma, Mels Hoogendoorn, Anne Giraut, Stephanie Antunes, Marian Stevens-Kroef, Joop H. Jansen, Aniek O. de Graaf, Fabio Efficace, Emanuele Ammatuna, Quentin Levesque, Ralph Wäsch, Heiko Becker, Nicole Blijlevens, Ulrich Dührsen, Frédéric Baron, Stefan Suciu, Adriano Venditti, Gerwin Huls

    Erschienen: 2026-08DOI: 10.1016/j.bneo.2026.100246

  6. Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia

    Yoke Seng Lee, Jonathan D. Good, Noha Awais, Benjamin K. Eschle, Maia S. Lineberry, Jingting Lin, Mark Wunderlich, Jenna Thibodeau, Holly Edwards, Jessica L. Teo, Sarah Bibeau, Morgan Wollman, George Karadimov, Nurefsan Sariipek, Basit Salik, Jean Acosta, Jenny Noel, David G. J. Cucchi, Erica A. K. DePasquale, Prafulla C. Gokhale, Jerome Ritz, Yubin Ge, Peter G. Miller, Fadi J. Najm, Richard M. Stone, Jacqueline S. Garcia, Andrew A. Lane, Courtney L. Jones, Peter van Galen

    Erschienen: 2026-05DOI: 10.1016/j.bneo.2026.100202

Jahrgänge

2026 · 1502025 · 1232024 · 46

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.